1. Home
  2. OSUR vs AQST Comparison

OSUR vs AQST Comparison

Compare OSUR & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OraSure Technologies Inc.

OSUR

OraSure Technologies Inc.

HOLD

Current Price

$2.42

Market Cap

177.2M

Sector

Health Care

ML Signal

HOLD

Logo Aquestive Therapeutics Inc.

AQST

Aquestive Therapeutics Inc.

HOLD

Current Price

$5.81

Market Cap

809.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OSUR
AQST
Founded
2000
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
177.2M
809.3M
IPO Year
1986
2018

Fundamental Metrics

Financial Performance
Metric
OSUR
AQST
Price
$2.42
$5.81
Analyst Decision
Hold
Strong Buy
Analyst Count
2
7
Target Price
$3.00
$10.00
AVG Volume (30 Days)
834.3K
2.4M
Earning Date
11-05-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$125,703,000.00
$43,397,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3.70
$52.69
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.08
$2.12
52 Week High
$4.22
$7.55

Technical Indicators

Market Signals
Indicator
OSUR
AQST
Relative Strength Index (RSI) 45.97 43.84
Support Level $2.42 $5.99
Resistance Level $2.65 $6.44
Average True Range (ATR) 0.11 0.32
MACD 0.02 -0.03
Stochastic Oscillator 34.92 11.37

Price Performance

Historical Comparison
OSUR
AQST

About OSUR OraSure Technologies Inc.

OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.

About AQST Aquestive Therapeutics Inc.

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

Share on Social Networks: